Correlation Between Biotechnology Ultrasector and Ultra Nasdaq-100

Can any of the company-specific risk be diversified away by investing in both Biotechnology Ultrasector and Ultra Nasdaq-100 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biotechnology Ultrasector and Ultra Nasdaq-100 into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Biotechnology Ultrasector Profund and Ultra Nasdaq 100 Profunds, you can compare the effects of market volatilities on Biotechnology Ultrasector and Ultra Nasdaq-100 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biotechnology Ultrasector with a short position of Ultra Nasdaq-100. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biotechnology Ultrasector and Ultra Nasdaq-100.

Diversification Opportunities for Biotechnology Ultrasector and Ultra Nasdaq-100

-0.08

Correlation Coefficient

Biotechnology Ultrasector  Ultra Nasdaq-100

Good diversification

The 3 months correlation between Biotechnology and Ultra is -0.08. Overlapping area represents the amount of risk that can be diversified away by holding Biotechnology Ultrasector Prof and Ultra Nasdaq 100 Profunds in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ultra Nasdaq 100 and Biotechnology Ultrasector is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biotechnology Ultrasector Profund are associated (or correlated) with Ultra Nasdaq-100. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ultra Nasdaq 100 has no effect on the direction of Biotechnology Ultrasector i.e., Biotechnology Ultrasector and Ultra Nasdaq-100 go up and down completely randomly.

Pair Corralation between Biotechnology Ultrasector and Ultra Nasdaq-100

Assuming the 90 days horizon Biotechnology Ultrasector is expected to generate 5.8 times less return on investment than Ultra Nasdaq-100. In addition to that, Biotechnology Ultrasector is 1.11 times more volatile than Ultra Nasdaq 100 Profunds. It trades about 0.02 of its total potential returns per unit of risk. Ultra Nasdaq 100 Profunds is currently generating about 0.1 per unit of volatility. If you would invest  4,265  in Ultra Nasdaq 100 Profunds on September 5, 2024 and sell it today you would earn a total of  7,514  from holding Ultra Nasdaq 100 Profunds or generate 176.18% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	99.8%
Values	Daily Returns

Biotechnology Ultrasector Prof  vs.  Ultra Nasdaq 100 Profunds

Biotechnology Ultrasector

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Biotechnology Ultrasector Profund has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong basic indicators, Biotechnology Ultrasector is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Ultra Nasdaq 100

Risk-Adjusted Performance

13 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Ultra Nasdaq 100 Profunds are ranked lower than 13 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak forward indicators, Ultra Nasdaq-100 showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Biotechnology Ultrasector and Ultra Nasdaq-100

The main advantage of trading using opposite Biotechnology Ultrasector and Ultra Nasdaq-100 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biotechnology Ultrasector position performs unexpectedly, Ultra Nasdaq-100 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ultra Nasdaq-100 will offset losses from the drop in Ultra Nasdaq-100's long position.

The idea behind Biotechnology Ultrasector Profund and Ultra Nasdaq 100 Profunds pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.